No Data
No Data
RBC Keeps Alcon at Outperform Ahead of Q1 Results
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* With UNITY VCS and UNITY CS
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $120.75
NanoDrops Names Daria Lemann-Blumenthal as CEO
AlphaValue/Baader Europe Upgrades Alcon to Add, Lowers PT
Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk
loading...